AI Will Extend Lifespan to 150 Years, Anthropic CEO

Headlines promise us eternal youth thanks to neural networks. But is this actually reality? In October 2024, Anthropic CEO Dario Amodei published a massive essay titled Machines of Loving Grace, in which he suggested that powerful artificial intelligence could accelerate the development of biology and medicine so drastically that 50 to 100 years of progress might be achieved in just 5 to 10 years.

Among the potential consequences of such a leap, he named an increase in human lifespan to approximately 150 years. Later, at the World Economic Forum in Davos in January 2025, Amodei reiterated this thought, emphasizing the compression of scientific timelines. Crucially, this is not an announcement of an already achieved medical breakthrough. It is a speculative futurist forecast, which the author himself openly acknowledges.

How AI is supposed to "compress" a century into a decade

Amodei's logic rests on the premise that many medical problems remain unsolved not due to a fundamental lack of knowledge, but because of the sheer complexity of processing vast, fragmented datasets. According to his assessment, AI could assist researchers in several key areas:

• Discovery of aging biomarkers. AI will help rapidly identify measurable biological indicators that accurately predict an organism's state and its specific response to various therapies.
• Modeling complex biological processes. Just as AlphaFold revolutionized protein structure prediction, new advanced models could eventually simulate the behavior of entire cells or tissues in silico.
• Accelerating drug development. Algorithms will more efficiently filter out unpromising candidate molecules in the earliest stages, drastically reducing the number of failed, time-consuming, and costly experiments.

Amodei references a historical precedent: in the 20th century, the global average life expectancy rose from roughly 40 to 75 years. He reasons that the achievements of the next century could theoretically deliver another comparable increase, provided AI removes the current bottlenecks in research speed.

What science says: the gap between forecast and reality

Despite the optimism of tech leaders, the broader scientific community views these aggressive timelines with heavy skepticism. Here is why:

1. The Data Bottleneck. As Reuters noted in October 2026, AI critically lacks high-quality, comprehensive biological data to build truly accurate models of living systems. Simulating a human cell in a computer remains far from biological reality.

2. Clinical Trial Limitations. A molecule that works perfectly in code can prove highly toxic or ineffective in a human body. An August 2026 review in Nature Reviews Drug Discovery emphasized that most AI-driven pharmaceutical projects remain in preclinical stages. Concrete evidence of AI's massive impact on actual clinical outcomes is still largely lacking.

3. Mice Are Not Humans. Amodei mentions experiments where certain compounds extended the maximum lifespan of lab mice by 25-50%. However, success in rodents does not guarantee similar results in humans. Furthermore, extending maximum lifespan in a controlled animal group is entirely different from raising the average life expectancy of the global human population.

Anthropic's own clarification

In a July 2026 interview with Le Monde, Anthropic President Daniela Amodei (Dario's sister) clarified the context of these bold statements. She stressed that this is about the theoretical possibility of accelerating scientific discovery, not a guaranteed "cure for aging" or an immortality pill.

According to her, a more grounded and realistic near-term goal is using AI to help patients suffering from cardiovascular diseases, chronic pain, and other conditions that directly impact the quality of life, rather than just obsessing over its absolute duration.

The Bottom Line

Dario Amodei's 150-year lifespan prediction remains a bold hypothesis, not an established scientific fact. Artificial intelligence is undoubtedly becoming a transformative tool for biologists, capable of accelerating the search for new drug targets and the analysis of complex medical data.

However, bridging the gap between computational models and safe, effective human treatments requires time, massive funding, and, above all, rigorous proof of efficacy. Before AI can truly "compress" a century of medical breakthroughs into a single decade, science must first overcome fundamental limitations in our understanding of human biology.